Gilead Sciences Inc
(XTER:GIS)
€
117.92
+0.72 (+0.61%)
Market Cap: 144.73 Bil
Enterprise Value: 157.42 Bil
PE Ratio: 18.41
PB Ratio: 7.13
GF Score: 81/100 Gilead Sciences Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021 / 06:40PM GMT
Release Date Price:
€51.87
(-1.46%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
Good afternoon, everybody, and welcome to this afternoon session of our Global Healthcare Conference. I'm delighted to welcome our next company, Gilead Sciences, I presume known to everybody on the call. From Gilead, we're joined by Johanna Mercier, Chief Commercial Officer; and Andy Dickinson, Chief Financial Officer.
Johanna and Andy, thank you for joining our conference today and appearing on screen at least from California.
Johanna Mercier
Gilead Sciences, Inc. - Chief Commercial Officer
Thanks for having us.
Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO
Thank you. Thanks for having us.
Questions & Answers
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
So our format today is
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot